Micronutrients at the interface between inflammation and infection - ascorbic acid and calciferol. part 2: Calciferol and the significance of nutrient supplements

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 1, 2011, Pages 64-74

  Ströhle, Alexander ^a   Wolters, Maike ^a   Hahn, Andreas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Autoimmune diseases; Cathelicidins; Immune system; Infections; Micronutrients; Phagocytosis; Vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL; ASCORBIC ACID; CALCIFEDIOL; CALCITRIOL; CATHELICIDIN; COLECALCIFEROL; ERGOCALCIFEROL; ERGOSTEROL; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; SECOSTEROID; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; DENDRITIC CELL; ENZYME SYNTHESIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; METABOLISM; MONOCYTE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NUTRIENT; PHAGOCYTOSIS; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; STRESS; T LYMPHOCYTE;

EID: 79551625932     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811794352097     Document Type: Article

References (125)

1. Ströhle, A.; Wolters, M.; Hahn, A. Micronutrients at the interface between inflammation and infection α the examples of ascorbic acid and calciferol Part 1: General overview with focus on ascorbic acid. Inflamm. Allergy Drug Targets, 2010, 10(1), 54-63.
2. Lemire, J.M.; Adams, J.S.; Sakai, R.; Jordan, S.C. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest., 1984, 74, 657-661.
3. Rigby, W.F.; Stacy, T.; Fanger, M.W. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J. Clin. Invest., 1984, 74, 1451-1455.
4. Rigby, W.F.; Shen, L.; Ball, E.D.; Guyre, P.M.; Fanger, M.W. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood, 1984, 64, 1110-1115.
5. Bhalla, A.K.; Amento, E.P.; Clemens, T.L.; Holick, M.F.; Krane, S.M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab., 1983, 57, 1308-1310.
6. Provvedini, D.M.; Tsoukas, C.D.; Deftos, L.J.; Manolagas, S.C. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science, 1983, 221, 1181-1183.
7. Zipitis, C.S.; Akobeng, A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child., 2008, 93, 512-517.
8. Mathieu, C.; Badenhoop, K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends. Endocrinol. Metab., 2005, 16, 261-266.
9. Leventis, P.; Patel, S. Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology (Oxford), 2008, 47, 1617-1621.
10. Cutolo, M.; Otsa, K.; Uprus, M.; Paolino, S.; Seriolo, B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev., 2007, 7, 59-64.
11. Edlich, R.; Mason, S.S.; Chase, M.E.; Fisher, A.L.; Gubler, K.; Long, W.B.3rd.; Newkirk, A.T. Revolutionary advances in the prevention of demyelinating diseases. J. Environ. Pathol. Toxicol. Oncol., 2009, 28, 143-152.
12. Pierrot-Deseilligny, C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J. Neurol., 2009, 256, 1468-1479.
13. Cantorna, M.T. Vitamin D and multiple sclerosis: an update. Nutr. Rev., 2008, 66(Suppl 2), S135-138.
14. Lehmann, B. Role of the vitamin D3 pathway in healthy and diseased skin-facts, contradictions and hypotheses. Exp. Dermatol., 2009, 18, 97-108.
15. Wolters, M. Diet and psoriasis: experimental data and clinical evidence. Br. J. Dermatol., 2005, 153, 706-714.
16. Lim, W.C.; Hanauer, S.B.; Li, Y.C. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol., 2005, 2, 308-315.
17. Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus, 2008, 17, 6-10.
18. Kamen, D.; Aranow, C. Vitamin D in systemic lupus erythematosus. Curr. Opin. Rheumatol., 2008, 20, 532-537.
19. Norman, A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr., 2008, 88, 491S-499S.
20. Dusso, A.S.; Brown, A.J.; Slatopolsky, E. Vitamin D. Am. J. Physiol. Renal Physiol., 2005, 289, F8-28.
21. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med., 2007, 357, 266-281.
22. Wolters, M.; Ströhle, A.; Hahn, A. Neue Erkenntnisse zu Vitamin D und Vitamin B12. Dtsch. Apothek. Z., 2005, 145, 221-228.
23. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr., 2004, 80(Suppl 6), 1678S-1688S.
24. Bouillon, R.; Van Cromphaut, S.; Carmeliet, G. Intestinal calcium absorption: Molecular vitamin D mediated mechanisms. J. Cell Biochem., 2003, 88, 332-339.
25. Hoenderop J.G.; Nilius B.; Bindels R.J. Calcium absorption across epithelia. Physiol Rev., 2005, 85, 373-422.
26. Boros. S.; Bindels, R.J.; Hoenderop, J.G. Active Ca(2+) reabsorption in the connecting tubule. Pflugers Arch., 2009, 458, 99-109.
27. Zehnder, D.; Bland, R.; Williams, M.C.; McNinch, R.W.; Howie, A.J.; Stewart, P.M.; Hewison, M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab., 2001, 86, 888-894.
28. Overbergh, L.; Decallonne, B.; Valckx, D.; Verstuyf, A.; Depovere, J.; Laureys, J.; Rutgeerts, O.; Saint-Arnaud, R.; Bouillon, R.; Mathieu, C. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol., 2000, 120, 139-146.
29. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C.; Kamen, D.L.; Wagner, M.; Bals, R.; Steinmeyer, A.; Zügel, U.; Gallo, R.L.; Eisenberg, D.; Hewison, M.; Hollis, B.W.; Adams, J.S.; Bloom, B.R.; Modlin, R.L. Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science, 2006, 311, 1770-1773.
30. Hewison, M.; Freeman, L.; Hughes, S.V.; Evans, K.N.; Bland, R.; Eliopoulos, A.G.; Kilby, M.D.; Moss, P.A.; Chakraverty, R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol., 2003, 170, 5382-5390.
31. Sigmundsdottir, H.; Pan, J.; Debes, G.F.; Alt, C.; Habtezion, A.; Soler, D.; Butcher, E.C. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol., 2007, 8, 285-293.
32. Chen, S.; Sims, G.P.; Chen, X.X.; Gu, Y.Y.; Chen, S.; Lipsky, P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol., 2007, 179, 1634-1647.
33. Cadranel, J.; Garabedian, M.; Milleron, B.; Guillozo, H.; Akoun, G.; Hance, A.J. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J. Clin. Invest., 1990, 85, 1588-1593.
34. Mora, J.R.; Iwata, M.; von Andrian, U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol., 2008, 8, 685-698.
35. Bikle, D. Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab., 2009, 94, 26-34.
36. Guyton, K.Z.; Kensler, T.W.; Posner, G.H. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr. Rev., 2003, 61, 227-238.
37. Adams, J.S.; Hewison, M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4, 80-90.
38. Bikle, D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens., 2008, 17, 348-352.
39. Ströhle, A.; Hahn, A. Bedeutung von Mikronährstoffen für die Immunkompetenz MMW-Fortschr. Med. Originalien. III, 2009, 151, 133-141.
40. Bals, R.; Wilson, J.M. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci., 2003, 60, 711-720.
41. Nijnik, A.; Hancock, R.E. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol., 2009, 16, 41-47.
42. Peric, M.; Koglin, S.; Ruzicka, T.; Schauber, J. Cathelicidins: multifunctional defense molecules of the skin. Dtsch. Med. Wochenschr., 2009, 134, 35-38.
43. Schauber, J.; Gallo, R.L. The vitamin D pathway: a new target for control of the skin's immune response? Exp. Dermatol., 2008, 17, 633-639.
44. Yamasaki, K.; Gallo, R.L. Antimicrobial peptides in human skin disease. Eur. J. Dermatol., 2008, 18, 11-21.
45. Liu, P.T.; Modlin, R.L. Human macrophage host defense against Mycobacterium tuberculosis. Curr. Opin. Immunol., 2008, 20, 371-376.
46. Zasloff, M. Fighting infections with vitamin D. Nat. Med., 2006, 12, 388-390.
47. VanAmerongen, B.M.; Dijkstra, C.D.; Lips, P.; Polman, C.H. Multiple sclerosis and vitamin D: an update. Eur. J. Clin. Nutr., 2004, 58, 1095-109.
48. Dalmay, F.; Bhalla, D.; Nicoletti, A.; Cabrera-Gomez, J.A.; Cabre, P.; Ruiz, F.; Druet-Cabanac, M.; Dumas, M.; Preux, P.M. Multiple sclerosis and solar exposure before the age of 15 years: casecontrol study in Cuba, Martinique and Sicily. Mult. Scler., 2010, 16, 899-908.
49. Beretich, B.D.; Beretich, T.M. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult. Scler., 2009, 15, 891-898.
50. Sloka, J.S.; Pryse-Phillips, W.E.; Stefanelli, M. The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can. J. Neurol. Sci., 2008, 35, 69-74.
51. van der Mei, I.A.; Ponsonby, A.L.; Blizzard, L.; Dwyer, T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology, 2001, 20, 168-174.
52. Vukusic, S.; Van, Bockstael, V.; Gosselin, S.; Confavreux, C. Regional variations in the prevalence of multiple sclerosis in French farmers. J. Neurol. Neurosurg. Psychiatry, 2007, 78, 707-709.
53. Pugliatti, M.; Rosati, G.; Carton, H.; Riise, T.; Drulovic, J.; Vécsei, L.; Milanov, I. The epidemiology of multiple sclerosis in Europe. Eur. J. Neurol., 2006, 13, 700-722.
54. Norman, J.E.; Kurtzke, J.F.; Beebe, G.W. Epidemiology of multiple sclerosis in US veterans: 2. Latitude, climate and the risk of multiple sclerosis. J. Chronic. Dis., 1983, 36, 551-559.
55. Acheson, E.D.; Bachrach, C.D.; Wright, F.M. Some comments on the relationship of the distribution of multiple s clerosis to latitude, solar radiation and other variables. Acta Psychiatr. Scand., 1960, 35, 132-147.
56. Freedman, D.M.; Dosemeci, M.; Alavanja, M.C. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup. Environ. Med., 2000, 57, 418-421.
57. Kurtzke J.F. Further considerations on the geographic distribution of multiple sclerosis. Acta Neurol. Scand., 1967, 43, 283-298.
58. Swank, R.L.; Lerstad, O.; Storm, A.; Barker, J. Multiple sclerosis in rural Norway: Its geographic and occupational incidence in relation to nutrition. N. Engl. J. Med., 1952, 246, 721-728.
59. Goldberg, P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part I: sunlight, dietary factors and epidemiology. Int. J. Environ. Studies, 1974, 6, 19-27.
60. Hayes, C.E.; Cantorna, M.T.; DeLuca, H.F. Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med., 1997, 216, 21-27.
61. Munger, K.L.; Levin, L.I.; Hollis, B.W.; Howard, N.S.; Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA., 2006, 296, 2832-2838.
62. Kragt, J.; van Amerongen, B.; Killestein, J.; Dijkstra, C.; Uitdehaag, B.; Polman, Ch.; Lips, P. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult. Scler., 2009, 15, 9-15.
63. Ascherio, A.; Munger, K.L. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol., 2007, 61, 504-513.
64. Souberbielle, J.C.; Body, J.J.; Lappe, J.M.; Plebani, M.; Shoenfeld, Y.; Wang, T.J.; Bischoff-Ferrari, H.A.; Cavalier, E.; Ebeling, P.R.; Fardellone, P.; Gandini, S.; Gruson, D.; Guérin, A.P.; Heickendorff, L.; Hollis, B.W.; Ish-Shalom, S.; Jean, G.; von Landenberg, P.; Largura, A.; Olsson, T.; Pierrot-Deseilligny, C.; Pilz, S.; Tincani, A.; Valcour, A.; Zittermann, A. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev., 2010, 9, 709-715.
65. Webb, A.R.; Engelsen, O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem. Photobiol., 2006, 82, 1697-1703.
66. Heaney, R.P. The Vitamin D requirement in health and disease. J. Steroid. Biochem. Mol. Biol., 2005, 97, 13-19.
67. Cashman, K.D.; Hill, T.R.; Lucey, A.J.; Taylor, N.; Seamans, K.M.; Muldowney, S.; Fitzgerald, A.P.; Flynn, A.; Barnes, M.S.; Horigan, G.; Bonham, M.P.; Duffy, E.M.; Strain, J.J.; Wallace, J.M.; Kiely, M. Estimation of the dietary requirement for vitamin D in healthy adults. Am. J. Clin. Nutr., 2008, 88, 1535-1542.
68. Cashman, K.D.; Wallace, J.M.; Horigan, G.; Hill, T.R.; Barnes, M.S.; Lucey, A.J.; Bonham, M.P.; Taylor, N.; Duffy, E.M.; Seamans, K.; Muldowney, S.; Fitzgerald, A.P.; Flynn, A.; Strain, J.; Kiely, M. Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age. Am. J. Clin. Nutr., 2009, 89, 1366-1374.
69. Aloia, J.F.; Patel, M.; Dimaano, R.; Li-Ng, M.; Talwar, S.A.; Mikhail, M.; Pollack, S.; Yeh, J.K. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am. J. Clin. Nutr., 2008, 87, 1952-1958.
70. Nelson, M.L.; Blum, J.M.; Hollis, B.W.; Rosen, C.; Sullivan, S.S. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J. Nutr., 2009, 139, 540-546.
71. Stephen, A.I.; Avenell, A. A systematic review of multivitamin and multimineral supplementation for infection. J. Hum. Nutr. Diet., 2006, 19, 179-190.
72. Hemilä, H. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med. Hypotheses, 1999, 52, 171-178.
73. Hemilä, H. Evidence-based medicine and the role of antioxidants in physically stressed people. Nutr. Rev., 2009, 67, 61-63.
74. Wejse, C.; Gomes, V.F.; Rabna, P.; Gustafson, P.; Aaby, P.; Lisse, I.M.; Anderson, P.L.; Glerup, H.; Sodemann, M. Vitamin D as Supplementary Treatment for Tuberculosis-A Double-blind Randomized Placebo-controlled Trial. Am. J. Respir. Crit. Care Med., 2009, 179, 843-850.
75. Li-Ng, M.; Aloia, J.F.; Pollack, S.; Cunha, B.A.; Mikhail, M.; Yeh, J.; Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect., 2009, 19, 1-9.
76. Aloia, J.F.; Li-Ng, M. Re: epidemic influenza and vitamin D. Epidemiol. Infect., 2007, 135, 1095-1096.
77. Douglas, R.M.; Hemilä, H.; Chalker, E.; Treacy, B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev., 2007, CD000980.
78. Packer, L.; Weber, S.U.; Rimbach, G. Molecular aspects of alphatocotrienol antioxidant action and cell signalling. J. Nutr., 2001, 131, 369S-373S.
79. Ströhle, A.; Wolters, M.; Hahn, A. Cobalamin-a critical nutritive element in the old age. Med. Monats. Pharm., 2005, 28, 60-66.
80. Shenkin, A. Micronutrients in health and disease. Postgrad. Med. J., 2006, 82, 559-567.
81. Bhaskaram, P. Immunobiology of mild micronutrient deficiencies. Br. J. Nutr., 2001, 85 (Suppl 2), S75-S80.
82. Bhaskaram, P. Micronutrient malnutrition, infection, and immunity: an overview. Nutr. Rev., 2002, 60, S40-45.
83. van Lettow, M.; Fawzi, W.W.; Semba, R.D. Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection. Nutr. Rev., 2003, 61, 81-90.
84. Colecraft, E. HIV/AIDS: nutritional implications and impact on human development. Proc. Nutr. Soc., 2008, 67, 109-113.
85. Drain, P.K.; Kupka, R.; Mugusi, F.; Fawzi, W.W. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am. J. Clin. Nutr., 2007, 85, 333-345.
86. Suttajit, M. Advances in nutrition support for quality of life in HIV+/AIDS. Asia Pac. J. Clin. Nutr., 2007, 16 (Suppl 1), 318-322.
87. Lee, G.J.; Chung, H.W.; Lee, K.H.; Ahn, H.S. Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J. Korean. Med. Sci., 2005, 20, 267-272.
88. Skrzydlewska, E.; Sulkowski, S.; Koda, M.; Zalewski, B.; Kanczuga-Koda, L.; Sulkowska, M. Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol., 2005, 11, 403-406.
89. Palan, P.R.; Woodall, A.L.; Anderson, P.S.; Mikhail, M.S. Alphatocopherol and alpha-tocopheryl quinone levels in cervical intraepithelial neoplasia and cervical cancer. Am. J. Obstet. Gynecol., 2004, 190, 1407-1410.
90. Ray, G.; Husain, S.A. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin. Biochem., 2001, 34, 71-76.
91. Lin, C.C.; Yin, M.C. B vitamins deficiency and decreased antioxidative state in patients with liver cancer. Eur. J. Nutr., 2007, 46, 293-299.
92. Tsao, S.M.; Yin, M.C.; Liu, W.H. Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr. Cancer, 2007, 59, 8-13.
93. Federico, A.; Iodice, P.; Federico, P.; Del Rio, A.; Mellone, M.C.; Catalano, G.; Federico, P. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur. J. Clin. Nutr., 2001, 55, 293-297.
94. Elango, N.; Samuel, S.; Chinnakkannu, P. Enzymatic and nonenzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation. Clin. Chim. Acta, 2006, 373, 92-98.
95. Büntzel, J.; Bruns, F.; Glatzel, M.; Garayev, A.; Mücke, R.; Kisters, K.; Schäfer, U.; Schönekaes, K.; Micke, O. Zinc concentrations in serum during head and neck cancer progression. Anticancer. Res., 2007, 27, 1941-1943.
96. Hahn, A.; Ströhle, A.; Wolters, M. Nutrition in rheumatic-type diseases. Med. Monatsschr. Pharm., 2007, 30, 138-146.
97. Hahn, A. Ernährung und Medikamente. In: Ernährungsmedizin. Biesalski, H.; Fürst, P.; Kasper, H., Kluthe, R., Pölert, W., Puchstein, C. (Hrsg.) (3. Aufl.) Stuttgart: Thieme, S. 2004; pp. 567-665.
98. Chan, L.N. Drug-nutrient interaction in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care, 2002, 5, 327-332.
99. Genser, D. Food and drug interaction: consequences for the nutrition/health status. Ann. Nutr. Metab., 2008, 52(Suppl 1), 29-32.
100. Aw, D.; Silva, A.B.; Palmer, D.B. Immunosenescence: emerging challenges for an ageing population. Immunology, 2007, 120, 435-446.
101. Hakim, F.T.; Gress, R.E. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens, 2007, 70, 179-189.
102. Hahn, A.; Ströhle, A. Nahrungsergänzungsmittel und diätetische Lebensmittel-Basiswissen für die Apotheke. Teil 2: Ernährungswissenschaftliche Aspekte. Dtsch. Apothek. Z., 2007, 147, 2038-2050.
103. Marian, M.; Sacks, G. Micronutrients and older adults. Nutr. Clin. Pract., 2009, 24, 179-195.
104. Langkamp-Henken, B.; Bender, B.S.; Gardner, E.M.; Herrlinger-Garcia, K.A.; Kelley, M.J.; Murasko, D.M.; Schaller, J.P.; Stechmiller, J.K.; Thomas, D.J.; Wood, S.M. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J. Am. Geriatr. Soc., 2004, 52, 3-12.
105. Kleinschnitz, C.; Meuth, S.G.; Kieseier, B.C.; Wiendl, H. Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006. Endocr. Metab. Immune Disord. Drug. Targets, 2007, 7, 35-63.
106. Cantorna, M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol., 2006, 92, 60-64.
107. Taylor, B.V.; Lucas, R.M.; Dear, K.; Kilpatrick, T.J.; Pender, M.P.; van der Mei, I.A.; Chapman, C.; Coulthard, A.; Dwyer, T.; McMichael, A.J.; Valery, P.C.; Williams, D.; Ponsonby, A.L. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult. Scler., 2010, 16, 398-405.
108. Islam, T.; Gauderman, W.J.; Cozen, W.; Mack, T.M. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology, 2007, 69, 381-388.
109. Staples, J.A.; Ponsonby, A.L.; Lim, L.L.; McMichael, A.J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect., 2003, 111, 518-523.
110. Hammond, S.R.; English, D.R.; McLeod, J.G. The agerange of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain, 2000, 123, 968-974.
111. Pryse-Phillips, W.E. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann. Neurol., 1986, 20, 323-328.
112. Westlund, K. Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway. Acta Neurol. Scand., 1970, 46, 455-483.
113. Burton, J.M.; Kimball, S.; Vieth, R.; Bar-Or, A.; Dosch, H.M.; Cheung, R.; Gagne, D.; D'Souza, C.; Ursell, M.; O'Connor, P. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology, 2010, 74, 1852-1859.
114. Wingerchuk, D.M.; Lesaux, J.; Rice, G.P.; Kremenchutzky, M.; Ebers, G.C. A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 2005, 76, 1294-1296.
115. Goldberg, P.; Fleming, M.C.; Picard, E.H. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses, 1986, 21, 193-200.
116. Willcox, A.; Richardson, S.J.; Bone, A.J.; Foulis, A.K.; Morgan, N.G. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol., 2009, 155, 173-181.
117. Eizirik, D.L.; Colli, M.L.; Ortis, F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol., 2009, 5, 219-226.
118. Danescu, L.G.; Levy, S.; Levy, J. Vitamin D and diabetes mellitus. Endocrine, 2009, 35, 11-17.
119. Alfonso, B.; Liao, E.; Busta, A.; Poretsky, L. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment. Diabetes Metab. Res. Rev., 2009, 25, 417-419.
120. Mohr, S.B.; Garland, C.F.; Gorham, E.D.; Garland, F.C. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia, 2008, 51, 1391-1398.
121. Sloka, S.; Grant, M.; Newhook, L.A. The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland. Acta Diabetol., 2010, 47, 73-78.
122. Keen, H.; Ekoe, J.M. The geography of diabetes mellitus. Br. Med. Bull., 1984, 40, 359-365.
123. Hyppönen, E.; Läärä, E.; Reunanen, A.; Järvelin, M.R.; Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet, 2001, 358, 1500-1503.
124. Cutolo, M. Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford)., 2009, 48, 210-212.
125. Merlino, L.A.; Curtis, J.; Mikuls, T.R.; Cerhan, J.R.; Criswell, L.A.; Saag, K.G.; Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum., 2004, 50, 72-77.